We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$125M
2
AAPL icon
Apple
AAPL
+$118M
3
AMZN icon
Amazon
AMZN
+$91.8M
4
META icon
Meta Platforms (Facebook)
META
+$70.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$404M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$82.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$41.8M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$36.3M
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 25.13%
2 Consumer Discretionary 10.52%
3 Financials 9.9%
4 Healthcare 8.91%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCB icon
1626
ArcBest
ARCB
$3.28B
$238K ﹤0.01%
1,993
-4,463
-69% -$454K
DAVA icon
1627
Endava
DAVA
$162M
$238K ﹤0.01%
1,419
-263
-16% -$40.7K
EDIT icon
1628
Editas Medicine
EDIT
$432M
$238K ﹤0.01%
8,990
+2,786
+45% +$95.9K
SONO icon
1629
Sonos
SONO
$1.86B
$238K ﹤0.01%
7,972
+692
+10% +$22K
IRBT
1630
DELISTED
iRobot
IRBT
$237K ﹤0.01%
3,607
+2,706
+300% +$214K
RGNX icon
1631
Regenxbio
RGNX
$720M
$237K ﹤0.01%
7,251
-423
-6% -$14.4K
PRK icon
1632
Park National Corp
PRK
$3.72B
$236K ﹤0.01%
1,720
+72
+4% +$9.57K
KRA
1633
DELISTED
Kraton Corporation
KRA
$236K ﹤0.01%
5,094
+2,848
+127% +$131K
CMRC
1634
Commerce.com Inc Series 1
CMRC
$179M
$234K ﹤0.01%
6,615
+2,818
+74% +$133K
CDE icon
1635
Coeur Mining
CDE
$19B
$234K ﹤0.01%
46,425
+30,882
+199% +$186K
CRSP icon
1636
CRISPR Therapeutics
CRSP
$5.22B
$234K ﹤0.01%
3,085
+173
+6% +$15.1K
RLAY icon
1637
Relay Therapeutics
RLAY
$4.37B
$234K ﹤0.01%
7,609
-1,131
-13% -$35.7K
ATI icon
1638
ATI
ATI
$31.4B
$233K ﹤0.01%
14,656
+1,637
+13% +$26.3K
CNM icon
1639
Core & Main
CNM
$8.62B
$233K ﹤0.01%
7,669
+6,893
+888% +$189K
EMLC icon
1640
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$233K ﹤0.01%
8,153
+7,564
+1,284% +$220K
SHE icon
1641
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$339M
$233K ﹤0.01%
2,287
-188
-8% -$19.5K
CALF icon
1642
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.9B
$232K ﹤0.01%
5,428
+2,686
+98% +$118K
SCHM icon
1643
Schwab US Mid-Cap ETF
SCHM
$15.3B
$232K ﹤0.01%
8,643
-43,077
-83% -$1.15M
FATE icon
1644
Fate Therapeutics
FATE
$294M
$231K ﹤0.01%
3,946
+291
+8% +$16.5K
MOMO
1645
Hello Group
MOMO
$867M
$231K ﹤0.01%
25,715
+7,152
+39% +$81.8K
RCKT icon
1646
Rocket Pharmaceuticals
RCKT
$367M
$231K ﹤0.01%
10,589
+1,938
+22% +$52.9K
MMP
1647
DELISTED
Magellan Midstream Partners, L.P.
MMP
$231K ﹤0.01%
4,964
+2,039
+70% +$96.3K
TWST icon
1648
Twist Bioscience
TWST
$7.85B
$230K ﹤0.01%
2,965
+2,643
+821% +$271K
ARGO
1649
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$230K ﹤0.01%
3,960
+586
+17% +$33K
KDNY
1650
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$230K ﹤0.01%
14,127
+9,430
+201% +$134K
64 65
66
67 68

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.